Description
BMS-936558-01 is an investigational drug being studied by Bristol-Myers Squibb. It is currently in Phase 1 clinical trials for advanced solid tumors, including colorectal cancer. The goal of these early trials is primarily to determine the safety and tolerability of the drug, as well as to find the best dose to use in future studies. It is being tested both alone (monotherapy) and in combination with other treatments like nivolumab (an immunotherapy drug) or docetaxel (a chemotherapy drug). Because it is in Phase 1, its effectiveness in treating colorectal cancer is not yet known. This is a first-in-human study, meaning it is being tested in people for the first time.
Mechanism of Action
The specific way BMS-936558-01 works (its mechanism of action) is still being investigated in clinical trials. It is being studied to see how it affects advanced solid tumors.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Category | Other Medications |
 EMA Status | Not submitted to EMA |
 Spain Access | Not available |
| Clinical Trials | 1 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.